Glimipack MP 2mg/500mg/15mg Tablet
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimipack MP 2mg/500mg/15mg Tablet
Metformin/Glimepiride/Pioglitazone 2mg/500mg/15mg tablets offer combined blood glucose management. This medication, used alongside diet and exercise, enhances blood sugar control in adult type 2 diabetics by improving insulin effectiveness, thus reducing elevated blood sugar. Dosage and frequency should strictly follow your physician's instructions. Administer with food to mitigate potential stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to minimize potential side effects.
Uses of Glimipack MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimipack MP 2mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Glimipack MP 2mg/500mg/15mg tablet with a meal.
Common Side effects of Glimipack MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimipack MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Glimipack MP 2mg/500mg/15mg Tablet should be administered with a meal.
How Glimipack MP 2mg/500mg/15mg Tablet works:
Glimipack MP 2mg/500mg/15mg tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications utilize distinct pathways to optimize blood glucose management when monotherapy or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimipack MP 2mg/500mg/15mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glimipack MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimipack MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use the 2mg/500mg/15mg Glimipack MP tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glimipack MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimipack MP 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimipack MP 2mg/500mg/15mg Tablet :
Should you forget to take your Glimipack MP 2mg/500mg/15mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimipack MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently